NEW YORK (GenomeWeb) – Danaher today initiated its earning outlook for 2019, saying EPS is anticipated to be in the range of $4.02 to $4.12.

On a non-GAAP basis, EPS is expected to be in the range of $4.75 to $4.85, which assumes non-GAAP core revenue growth of about 4 percent. The Washington-based conglomerate, which owns Cepheid, Sciex, Beckman Coulter, and other life sciences and diagnostics companies, issued its guidance ahead of its annual investor and analyst meeting being held today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.